Low-dose atropine for myopia progression in children: a 2017–2024 systematic review and meta-analysis of randomized placebo-controlled trials

Puntos clave

• Low-dose atropine was associated with a reduction in myopia progression in children, indicating its effectiveness.
• The meta-analysis combined outcomes from multiple randomized placebo-controlled trials to strengthen findings.
• Systematic review included studies from 2017 to 2024, providing a comprehensive overview of current evidence.
• Findings may influence future treatment guidelines for managing myopia in pediatric populations.